Thirty-five generic drugmakers will produce low-cost versions of Pfizer Inc's (NYSE: PFE) COVID-19 pill, Paxlovid, to expand supplies of the highly effective drug in lower-income regions. Pfizer ...
The 35 companies that will produce versions of Paxlovid or its active ingredient are based in 12 countries Thirty five generic drugmakers around the world will make cheap versions of Pfizer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback